| |
Home : D : Danaparoid : Abciximab and Danaparoid
Effects and Recommendation :
Resulting In: increased bleeding tendencies Co-administration of Abciximab and Danaparoid may increase the risk of bleeding.
Avoid this combination if possible.
Severity of the interaction : 5/6
|
Information on this interaction is found in the following publications :
----------
Product Information. Abciximab (ReoPro). Eli Lilly and Company, 1998.
Publication : Abciximab (ReoPro) by Product Information
> Product Information - -
|
|
|
|
|
